In the tumor-bearing humanized mice, the percentages of tumor-infiltrating CD3+, CD4+ and CD8+ T cells were lower than those in blood and spleen (Figure 3A–C), while there were no significant changes in the percentage of CD19+ B cells (Figure 3D). This evidence concerns the gene CD4 and neoplasm.